MIR1181: A Potential Drug Target and Biomarker (G100302213)

MIR1181: A Potential Drug Target and Biomarker

Molecular Imaging and Research (MIR) has revolutionized the study of cancer biology, providing researchers with a deeper understanding of the genetic and molecular changes that occur in cancer cells. One of the most promising areas of research is the identification of potential drug targets and biomarkers for cancer treatment. In this article, we will explore MIR1181, a potential drug target and biomarker for cancer treatment.

MIR1181 is a gene that encodes a protein known as MIR1181, which is expressed in various tissues throughout the body, including the brain, lungs, and gastrointestinal tract. MIR1181 has been shown to play a role in cell signaling pathways, including the TGF-β pathway. This pathway is involved in cell growth, differentiation, and survival, and is a key factor in the development and progression of many types of cancer.

Research has shown that MIR1181 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancers. Additionally, studies have shown that MIR1181 is involved in the development and progression of many types of cancer, including breast cancer, ovarian cancer, and prostate cancer. This suggests that MIR1181 may be a valuable drug target for cancer treatment.

One of the key advantages of MIR1181 as a drug target is its expression in a wide range of tissues, making it an attractive target for cancer treatment. MIR1181 is also expressed in the brain, which suggests that it may be involved in the development and progression of cancer in this organ. This is an especially important target for cancer treatment, as the brain is difficult to target with drugs, and there is a high risk of unintended side effects.

In addition to its potential as a drug target, MIR1181 has also been shown to be a potential biomarker for cancer. Studies have shown that MIR1181 is expressed in various types of cancer, including breast, ovarian, and prostate cancers. This suggests that MIR1181 may be a valuable biomarker for the diagnosis and treatment of cancer.

One of the key challenges in the identification of MIR1181 as a potential drug target is its expression in various tissues and its involvement in multiple signaling pathways. This makes it difficult to understand its full role in cancer biology and to identify potential drug targets. However, research is ongoing to better understand the role of MIR1181 in cancer biology and to identify its potential as a drug target.

In conclusion, MIR1181 is a promising drug target and biomarker for cancer treatment. Its expression in various tissues and involvement in the TGF-β pathway make it an attractive target for cancer treatment. Further research is needed to fully understand its role in cancer biology and to identify its potential as a drug target.

Protein Name: MicroRNA 1181

The "MIR1181 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1181 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2